Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425641 · ClinicalTrials.gov registry record · Phase 2
MoST-Influenced Behavioral Intervention for Walking
A Phase 2 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 606
- Enrollment target
NCT05425641: Completed Phase 2 study, sponsored by Northwell Health.
NCT05425641 is a Phase 2 study that has completed, run by Northwell Health. The registered enrollment target is 606 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (356% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05425641, a Phase 2 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 606 participants
- Enrollment target
Study Summary
This study is a randomized, factorial experiment using the basic Science of Behavior Change (SOBC) approach to efficiently test the effects of four distinct behavior change techniques (BCTs), goal setting, action planning, self- monitoring and feedback, thought to engage one key behavioral mechanism of action (MoA) for improving daily walking by at least 1000 steps per day in persons who have been objectively verified as sedentary and are at risk for cardiovascular disease.
Primary Outcome
Self-efficacy, the hypothesized mechanism of action, will be assessed using the Self-Efficacy for Walking - Duration (SEW-DUR) scale, a 10-item measure assessing patient's capabilities to walk for durations of 5 to 50 minutes. Items are scored from 0 to 100%, with scores of 0% indicating participants are "not at all confident" they could walk for that duration and scores of 100% indicating the participants are "highly confident" they could walk that duration. Items are average to create a total
Interventions
- BEHAVIORAL Action Planning
- BEHAVIORAL Goal Setting
- BEHAVIORAL Self-Monitoring of Behavior
- BEHAVIORAL Feedback on Behavior
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 606 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-01-13 |
| Phase | Phase 2 |
What the finished NCT05425641 record still lists
NCT05425641 is an interventional study that assigns participants to a tested intervention. The registered 606 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (356% higher).
The record links to 0 conditions, and to 4 interventions - of which Action Planning is the first listed.
NCT05425641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05425641 about?
NCT05425641 is a clinical study titled "MoST-Influenced Behavioral Intervention for Walking". This study is a randomized, factorial experiment using the basic Science of Behavior Change (SOBC) approach to efficiently test the effects of four distinct behavior change techniques (BCTs), goal setting, action planning, self- monitoring and feedback, thought to engage one key behavioral mechanism...
What is the current status of trial NCT05425641?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 606 participants. The study started on 2022-09-12. Estimated completion is 2026-01-13.
What interventions are being tested in trial NCT05425641?
The interventions under investigation include: Action Planning (BEHAVIORAL), Goal Setting (BEHAVIORAL), Self-Monitoring of Behavior (BEHAVIORAL), Feedback on Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT05425641?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05425641's enrollment target sits among peer trials
606 53rd of 2000 higher than 1,948 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI